Kerlone

Betaxolol Hydrochloride, the active ingredient in Kerlone, is a beta blocker presented as an oral tablet for systemic use. It is employed to lower elevated blood pressure by reducing heart rate and cardiac output, primarily in adult patients with hypertension.

GNH USA supplies Kerlone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Its distribution network ensures timely delivery and compliance with local regulatory requirements.

Betaxolol Hydrochloride is a selective β1‑adrenergic blocker used in the management of hypertension and related cardiovascular conditions.

- Hypertension: lowers systolic and diastolic blood pressure, reducing cardiovascular risk. - Stable angina: decreases myocardial oxygen demand by slowing heart rate. - Post‑myocardial infarction prophylaxis: helps prevent recurrent ischemic events by controlling heart rate and blood pressure.

Betaxolol Hydrochloride may cause a range of adverse reactions, most of which are dose‑related and reversible upon discontinuation.

Common Side Effects: - Fatigue: feeling of reduced energy or tiredness. - Dizziness: light‑headed sensation, especially on standing. - Bradycardia: slower than normal heart rate. - Cold extremities: reduced peripheral circulation. - Headache: mild to moderate pain in the head. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe bradycardia: markedly low heart rate requiring medical attention. - Heart block: impaired electrical conduction in the heart. - Bronchospasm: narrowing of airways, especially in patients with asthma. - Hypotension: dangerously low blood pressure. - Allergic reactions: rash, itching, or swelling. - Depression: mood changes or persistent sadness.

Before initiating therapy with Betaxolol Hydrochloride, clinicians should consider several safety measures.

- Blood pressure monitoring: ensure adequate control and avoid excessive hypotension. - Heart rate assessment: watch for bradycardia, especially in patients with conduction disorders. - Asthma caution: use carefully in patients with reactive airway disease. - Discontinuation: avoid abrupt withdrawal to prevent rebound hypertension. - Renal impairment: adjust dose in patients with reduced kidney function. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Betaxolol Hydrochloride can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Calcium channel blockers (e.g., verapamil): may cause profound bradycardia. - Other antihypertensives (e.g., ACE inhibitors): increase risk of hypotension. - Clonidine: concurrent use can lead to severe blood pressure drops.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce antihypertensive effect. - Diuretics: can exacerbate electrolyte imbalances. - Insulin or oral hypoglycemics: beta‑blockade may mask hypoglycemia symptoms. - Antidepressants (SSRIs): may enhance bradycardic response.